LYFE CAPITAL
In our inaugural fund, we are only seeking biotechnology, pharmaceutical, medical device, diagnostic, healthcare service and digital health companies with an established product foundation but need a bit more capital to accelerate its growth in Greater China. During this critical time, we work closely with our portfolio companies and support their needs not only by providing capital but with market planning, talent acquisition, global expansion and global partnership support.
LYFE CAPITAL
Social Links:
Industry:
Biotechnology
Founded:
2014-01-01
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Mobile Non Scaleable Content Euro Person Schema Gravatar Profiles Gravity Forms Shutterstock Unsplash
Similar Organizations
6 Dimensions Capital
6 Dimensions Capital is a healthcare focused investment firm.
Comprendia
Comprendia is the only life science marketing firm.
Logos Capital
Logos Capital is a fundamental biotechnology-focused investment fund.
Magpie Pharmaceuticals
Magpie Pharmaceuticals is a biotechnology company.
Monograph Capital
Monograph Capital is a life sciences venture firm.
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-07-25 | MobiDrop | LYFE Capital investment in Series A - MobiDrop | 90 M CNY |
| 2022-06-02 | ProfoundBio | LYFE Capital investment in Series A - ProfoundBio | 70 M USD |
| 2022-05-16 | Starna Therapeutics | LYFE Capital investment in Series A - Starna Therapeutics | 150 M CNY |
| 2022-05-09 | Aspen Neuroscience | LYFE Capital investment in Series B - Aspen Neuroscience | 147.5 M USD |
| 2022-05-09 | Boyue Bio | LYFE Capital investment in Series A - Boyue Bio | 150 M CNY |
| 2022-04-26 | Elixir Clinical Research | LYFE Capital investment in Series A - Elixir Clinical Research | 52 M USD |
| 2022-04-11 | Shenji Bio | LYFE Capital investment in Series A - Shenji Bio | 300 M CNY |
| 2022-03-15 | Molecular Assemblies | LYFE Capital investment in Series B - Molecular Assemblies | 25.8 M USD |
| 2022-03-14 | Medilink Therapeutics | LYFE Capital investment in Series B - Medilink Therapeutics | 70 M USD |
| 2022-02-07 | Genepoint Biological Technology | LYFE Capital investment in Series C - Genepoint Biological Technology | 120 M CNY |